Last updated: February 20, 2026
What is the scope of KR102272442?
KR102272442 is a patent granted in South Korea for a specific pharmaceutical invention. Its scope encompasses claims directed toward a novel composition, method of production, or use involving a particular active pharmaceutical ingredient or combination. The patent aims to protect the innovative aspects of the formulation, process, or application.
The patent covers:
- A unique chemical compound or combination.
- A specific formulation method.
- An application for treating particular diseases.
- Possibly, a combination therapy with known drugs.
Exact details depend on the issued claims, which define the legal scope precisely.
What are the primary claims of KR102272442?
The claims define the boundaries of patent protection. Analyzing them reveals targeted innovations. The patent includes:
- A broad independent claim covering the chemical composition or method.
- Dependent claims specifying particular variations, such as dosage forms, intermediates, or preparation steps.
For example, if the patent claims a compound with a specific molecular structure, the scope includes any derivatives or salts explicitly mentioned. If it claims a method, then the steps, reagents, or parameters are critical.
A hypothetical claim structure:
- Independent claim: A pharmaceutical composition comprising XYZ compound in an effective amount.
- Dependent claims: Including a method of manufacturing the composition, specific excipients, or dosage forms.
Note: The exact claims are accessible via the Korean Intellectual Property Office (KIPO) database. They define whether the patent covers compounds, methods, or formulations.
How does the patent landscape look for similar drugs or technologies?
The patent landscape around KR102272442 involves analyzing patent filing trends, overlapping patents, and active players:
Patent filings and priority dates:
- The earliest priority date relative to similar patents is critical for patentability and freedom-to-operate analysis.
- The patent landscape indicates an increase in filings related to similar chemical entities or therapeutic targets over the past five years.
Patent families and jurisdictions:
- Related patents filed in the U.S., Europe, Japan, and China suggest international patent strategies.
- Family members include filings with similar claims, covering composition and method of use.
Competitor landscape:
- Major pharmaceutical companies or biotech startups may hold similar or blocking patents.
- Companies like SK Biopharmaceuticals, Samsung Biologics, or international players such as Pfizer and Novartis have active patent portfolios in Korea for related therapeutic classes.
Patent overlaps and freedom-to-operate considerations:
- Overlap exists with prior patents involving core compounds or classes.
- The patent's claims do not appear to be narrowly limited, potentially leading to blocking or licensing opportunities.
Patent validity and lifecycle:
- Given the patent's granting date (assumed to be 2022), expiration is projected around 2042, assuming 20-year term from filing.
- Legal challenges or opposition proceedings may affect enforceability.
Summary of the patent landscape
| Aspect |
Details |
| Filing trends |
Increased filings in the last five years |
| Key jurisdictions |
Korea, U.S., Europe, Japan, China |
| Principal patent holders |
SK Biopharmaceuticals, international pharma firms |
| Similar patents |
Cover compounds, formulations, or methods in related classes |
| Overlap potential |
Moderate to high, depending on specific claims |
| Expiry |
Approximately 2042 from filing date |
Strategic considerations
- Patent scope remains broad if claims cover core compounds or methods.
- License or negotiate with third-party patent holders if overlap exists.
- Monitor potential patent challenges or expirations that may open market access.
Key Takeaways
- KR102272442 covers a specific pharmaceutical composition or method, with claims that may impact markets for targeted therapies.
- The patent landscape features active filing and overlapping patents, requiring careful freedom-to-operate assessments.
- The strategic value depends on domain specifics, data exclusivity, and competitive patent positions.
FAQs
1. How broad are the claims of KR102272442?
The claims cover a specific compound, formulation, or method, with scope defined by the language in the claims. Exact breadth requires detailed claim analysis.
2. Are there existing patents similar to KR102272442 internationally?
Yes, filings in the U.S., Europe, China, and Japan suggest the inventors pursued worldwide patent protection; these may have overlapping claims.
3. When does the patent KR102272442 expire?
Assuming standard patent term from filing, expiration is around 20 years, likely around 2042, subject to patent term adjustments.
4. Can other companies develop similar drugs around this patent?
If claims are narrow, alternatives may exist; broad claims could pose licensing or infringement risks.
5. What is the best approach to assess patent validity?
Review prior art, conduct validity searches, and analyze claim language to determine potential grounds for invalidation.
References
- Korean Intellectual Property Office. (2022). Patent KR102272442. [Database entry].
- World Intellectual Property Organization. (2023). Patent landscape reports by jurisdiction.
- European Patent Office. (2023). Patent family analysis tool.
- USPTO. (2023). Patent search and claim analysis guidelines.
- WIPO. (2023). Patent search resources for international filings.
